Device typeHeparin anti-Xa IVD, kit, chromogenic: A collection of reagents and other associated materials intended to be used for the quantitative detection of heparin by measuring its ability to inhibit the activity of activated factor X (factor Xa) in a clinical specimen, using a chromogenic method. The assay is typically used to monitor anticoagulation therapy.
FDA categoryACTIVATED WHOLE BLOOD CLOTTING TIME
Device ID20763000433813
Single useYes
MRI safetyLabeling does not contain MRI Safety Information